The Biofire respiratory panel 2.1 is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and differentiation of multiple viral and bacterial respiratory organisms including nucleic acid from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), in Nasopharyngeal swabs obtained from individuals suspected of Covid-19 by their healthcare provider.